Sirt1 and Sirt6 Mediate Beneficial Effects of Rosiglitazone on Hepatic Lipid Accumulation

por Yang, Soo Jin, Choi, Jung Mook, Chang, Eugene, Park, Sung Woo, Park, Cheol-Young
Publicado 2014

Reduced Food Intake is the Major Contributor to the Protective Effect of Rimonabant on Islet in Established Obesity-Associated Type 2 Diabetes

por Jin, Sang-Man, Oh, Bae Jun, Lee, Suel, Choi, Jung Mook, Yang, Soo Jin, Park, Sung Woo, Kim, Kwang-Won, Kim, Jae Hyeon, Park, Cheol-Young
Publicado 2013

Depot-Specific Changes in Fat Metabolism with Aging in a Type 2 Diabetic Animal Model

por Park, Se Eun, Park, Cheol-Young, Choi, Jung Mook, Chang, Eugene, Rhee, Eun-Jung, Lee, Won-Young, Oh, Ki Won, Park, Sung Woo, Kang, Eun Seok, Lee, Hyun Chul, Cha, Bong Soo
Publicado 2016

Activation of Peroxisome Proliferator-Activated Receptor Gamma by Rosiglitazone Increases Sirt6 Expression and Ameliorates Hepatic Steatosis in Rats

por Yang, Soo Jin, Choi, Jung Mook, Chae, Seoung Wan, Kim, Won Jun, Park, Se Eun, Rhee, Eun Jung, Lee, Won Young, Oh, Ki Won, Park, Sung Woo, Kim, Sun Woo, Park, Cheol-Young
Publicado 2011